◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Telo Genomics Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00
Operating Revenue 0.00 0.00 0.00 0.00 0.00
Selling General And Administration 247,370 359,192 494,201 248,541 207,656
General And Administrative Expense 247,370 359,192 494,201 248,541 207,656
Research And Development 294,315 308,915 351,508 387,261 345,108
Other Operating Expenses -- -- -600.00 -21,585 --
Operating Expense 541,685 690,292 845,109 614,217 552,764
Operating Income -541,685 -690,292 -845,109 -614,217 -552,764
EBIT -541,685 -690,292 -845,109 -614,217 -552,764
Other Income Expense -- -- -- -- --
Special Income Charges -- -16,371 0.00 -- --
Pretax Income -541,685 -706,663 -845,109 -614,217 -552,764
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation -541,685 -706,663 -845,109 -614,217 -552,764
Net Income From Continuing Operation Net Minority Interest -541,685 -706,663 -845,109 -614,217 -552,764
Net Income Including Noncontrolling Interests -541,685 -706,663 -845,109 -614,217 -552,764
Net Income Common Stockholders -541,685 -706,663 -845,109 -614,217 -552,764
Net Income -541,685 -706,663 -845,109 -614,217 -552,764
EBITDA -538,922 -687,412 -842,229 -610,935 -547,354
Normalized EBITDA -538,922 -671,041 -842,229 -610,935 -547,354
Reconciled Depreciation 2,763 2,880 2,880 3,282 5,410
Basic EPS -0.01 -- -0.01 -0.01 -0.01
Diluted EPS -0.01 -- -0.01 -0.01 -0.01
Basic Average Shares 100.4M -- 100.0M 76.8M 74.6M
Diluted Average Shares 100.4M -- 100.0M 76.8M 74.6M
Total Unusual Items -- -16,371 0.00 -- --
Total Unusual Items Excluding Goodwill -- -16,371 0.00 -- --
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00
Normalized Income -541,685 -690,292 -845,109 -614,217 -552,764
Diluted NI Availto Com Stockholders -541,685 -706,663 -845,109 -614,217 -552,764
Net Income Continuous Operations -541,685 -706,663 -845,109 -614,217 -552,764
Other Gand A 247,370 359,192 494,201 248,541 207,656
Other Special Charges -- -- -- -- --
Total Expenses 541,685 690,292 845,109 614,217 552,764
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Cash And Cash Equivalents 486,508 789,293 1.2M 2.2M 328,272
Cash Cash Equivalents And Short Term Investments 486,508 789,293 1.2M 2.2M 328,272
Cash Financial 486,508 789,293 1.2M 2.2M --
Accounts Receivable 16,801 26,539 30,411 29,526 17,487
Receivables 16,801 26,539 30,411 29,526 17,487
Prepaid Assets 85,237 76,430 80,232 36,745 53,223
Current Assets 588,546 892,262 1.4M 2.3M 398,982
Gross PPE 952,147 950,072 950,072 946,822 946,822
Accumulated Depreciation -933,797 -931,034 -928,154 -925,274 -921,992
Net PPE 18,350 19,038 21,918 21,548 24,830
Goodwill And Other Intangible Assets 0.00 0.00 16,371 16,371 16,371
Other Intangible Assets -- -- 16,371 16,371 --
Total Non Current Assets 18,350 19,038 38,289 37,919 41,201
Total Assets 606,896 911,300 1.4M 2.4M 440,183
Payables And Accrued Expenses 633,600 396,319 274,562 603,769 403,065
Current Liabilities 633,600 396,319 274,562 603,769 403,065
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00 0.00
Total Liabilities Net Minority Interest 633,600 396,319 274,562 603,769 403,065
Common Stock 24.6M 24.6M 24.6M 24.6M 22.3M
Capital Stock 24.6M 24.6M 24.6M 24.6M 22.3M
Additional Paid In Capital 6.4M 6.4M 6.4M 6.2M 6.1M
Retained Earnings -31.1M -30.5M -29.8M -29.0M -28.4M
Common Stock Equity -26,704 514,981 1.1M 1.7M 37,118
Stockholders Equity -26,704 514,981 1.1M 1.7M 37,118
Total Equity Gross Minority Interest -26,704 514,981 1.1M 1.7M 37,118
Total Capitalization -26,704 514,981 1.1M 1.7M 37,118
Net Tangible Assets -26,704 514,981 1.1M 1.7M 20,747
Tangible Book Value -26,704 514,981 1.1M 1.7M 20,747
Working Capital -45,054 495,943 1.1M 1.7M -4,083
Invested Capital -26,704 514,981 1.1M 1.7M 37,118
Share Issued 100.4M 100.0M 100.0M 100.0M 74.6M
Ordinary Shares Number 100.4M 100.0M 100.0M 100.0M 74.6M
Machinery Furniture Equipment 952,147 950,072 950,072 946,822 946,822
Other Equity Interest -- 50,369 25,753 -- --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Operating Cash Flow -300,710 -459,402 -995,967 -405,792 -467,573
Cash Flow From Continuing Operating Activities -300,710 -459,402 -995,967 -405,792 -467,573
Depreciation And Amortization 2,763 2,880 2,880 3,282 5,410
Depreciation Amortization Depletion 2,763 2,880 2,880 3,282 5,410
Stock Based Compensation -- 73,963 194,088 0.00 0.00
Change In Working Capital 238,212 129,431 -373,579 205,143 79,781
Change In Receivables 9,738 3,872 -885.00 -12,039 13,762
Change In Payables And Accrued Expense 237,281 121,756 -329,206 200,704 27,478
Other Non Cash Items -- 24,616 -- -- --
Capital Expenditure -2,075 -- -- -- --
Purchase Of PPE -2,075 0.00 -3,250 0.00 0.00
Net PPE Purchase And Sale -2,075 0.00 -3,250 0.00 0.00
Investing Cash Flow -2,075 0.00 -3,250 0.00 0.00
Cash Flow From Continuing Investing Activities -2,075 0.00 -3,250 0.00 0.00
Repayment Of Debt -- 0.00 -- -- --
Net Issuance Payments Of Debt -- 0.00 -- -- --
Issuance Of Capital Stock -- 0.00 0.00 -- --
Net Common Stock Issuance -- 0.00 0.00 -- --
Financing Cash Flow -- 0.00 -491.00 2.3M -175.00
Cash Flow From Continuing Financing Activities -- 0.00 -491.00 2.3M -175.00
Changes In Cash -302,785 -459,402 -999,708 1.9M -467,748
Beginning Cash Position 789,293 1.2M 2.2M 328,272 796,020
End Cash Position 486,508 789,293 1.2M 2.2M 328,272
Free Cash Flow -302,785 -459,402 -999,217 -405,792 -467,573
Change In Prepaid Assets -8,807 3,803 -43,488 16,478 38,541
Common Stock Issuance -- 0.00 0.00 -- --
Depreciation 2,763 2,880 2,880 3,282 5,410
Long Term Debt Payments -- 0.00 -- -- --
Net Income From Continuing Operations -541,685 -706,663 -845,109 -614,217 -552,764
Net Long Term Debt Issuance -- 0.00 -- -- --
Net Other Financing Charges -- 0.00 -491.00 -219,977 -175.00
Operating Gains Losses -- -- -- -- --
Proceeds From Stock Option Exercised -- -- -- -- --
NEWS
Loading news...
TRENDING
Loading...